Targeting Pathogenic Myelopoiesis in Pancreatic Cancer | MicrobiomeTrials← Back to trialsNCT07765316
Targeting Pathogenic Myelopoiesis in Pancreatic Cancer
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-09-30Est. Completion: 2027-12-31
Enrollment target: 100 participants Other microbiome trials you might be interested in
Oesophageal Squamous Cell CarcinomaOesophageal AdenocarcinomaGastric AdenocarcinomaPancreatic Ductal Adenocarcinoma (PDAC)CholangiocarcinomaHepatocellular Carcinoma (HCC)Colorectal Adenocarcinoma
The investigators of this study are developing a simple breath test to help detect gastrointestinal (gut) cancers earlie…
Maidstone, United KingdomEst. completion Feb 2, 2028
Pancreatic Cancer
This study is a multi center, open-label, dose escalation, Phase I/IIa study of EF-009 in up to 30 patients with borderl…
Multiple LocationsEst. completion Dec 31, 2029
Neuroendocrine TumorsCarcinoid Tumor
Gastroentero-pancreatic neuroendocrine tumours (GEP-NETs) are regarded as a fairly rare disease. They are derived from t…
Aarau, SwitzerlandCompleted Aug 31, 2025